MedPath

Feasibility and safety of Umbilical cord blood as a potential source for blood transfusion in neonates.

Not Applicable
Completed
Conditions
Health Condition 1: null- umbilical cord blood collection and storage
Registration Number
CTRI/2016/12/007536
Lead Sponsor
Institute of Child Health and hospital for ChildrenDepartment of Neonatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Mothers who consent for collection and storage of their Umbilical cord blood at the time of delivery

Exclusion Criteria

1. Mothers diagnosed with HIV/HBV/HCV/Malaria/Syphilis infection

2. Mothers who opt for stem cell storage from Umbilical cord blood.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Quantity of umbilical cord blood (ml) that can be collected per neonate across different gestational age, birth weight, mode of delivery and collection method 2. Change in Parameters of collected and stored <br/ ><br>umbilical cord blood <br/ ><br>â?¢ pH (0, 7, 14, 21, 30 days) <br/ ><br>â?¢ Potassium (0, 7,14,21,30 days) <br/ ><br>â?¢ Haematocrit (0, 7,14,21,30 days) <br/ ><br>â?¢ Free Haemoglobin (0, 14, 28days) <br/ ><br>â?¢ Cord blood culture (0,14 days) <br/ ><br> <br/ ><br>Timepoint: 0, 7, 14, 21, 30 days
Secondary Outcome Measures
NameTimeMethod
Quantity of packed RBC(ml) that can be <br/ ><br>separated from the umbilical cord blood after <br/ ><br>collection.Timepoint: day 1
© Copyright 2025. All Rights Reserved by MedPath